Financials Prediction Markets

FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
Yes
No
$1,842 vol
FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (in 2026)
Yes
No
$4,230 vol
FDA decision: BBP-418 by Ml Bio Solutions Inc. (in 2026)
Yes
No
$944 vol
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading
Loading